Industry: Medical Devices & Consumables
Published Date: 2025-08-01
Pages: 107 Pages
Report ld: 4830167
Request Sample
Customized Report
The global Single Cell Transcriptome Sequencing Platform market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Single Cell Transcriptome Sequencing Platform market competitiveness, regional economic performance, and supply chain configurations.
Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
The North America Single Cell Transcriptome Sequencing Platform market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Single Cell Transcriptome Sequencing Platform include 10x Genomics, BD, BGI, Singleron Bio, Seekgene, ThunderBio, Tenk Genomics, MobiDrop, BioMarker, Dynamic Biosystems, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Single Cell Transcriptome Sequencing Platform market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Single Cell Transcriptome Sequencing Platform market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Microfluidic Microwell Platform in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Immunology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Single Cell Transcriptome Sequencing Platform value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Single Cell Transcriptome Sequencing Platform Product Scope
1.2 Single Cell Transcriptome Sequencing Platform by Type
1.2.1 Global Single Cell Transcriptome Sequencing Platform Sales by Type (2020 & 2024 & 2031)
1.2.2 Droplet Microfluidic Platform
1.2.3 Microfluidic Microwell Platform
1.3 Single Cell Transcriptome Sequencing Platform by Application
1.3.1 Global Single Cell Transcriptome Sequencing Platform Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Cancer
1.3.3 Immunology
1.3.4 Neurology
1.3.5 Others
1.4 Global Single Cell Transcriptome Sequencing Platform Market Estimates and Forecasts (2020-2031)
1.4.1 Global Single Cell Transcriptome Sequencing Platform Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Single Cell Transcriptome Sequencing Platform Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Single Cell Transcriptome Sequencing Platform Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Single Cell Transcriptome Sequencing Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Single Cell Transcriptome Sequencing Platform Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Single Cell Transcriptome Sequencing Platform Sales Market Share by Region (2020-2025)
2.2.2 Global Single Cell Transcriptome Sequencing Platform Revenue Market Share by Region (2020-2025)
2.3 Global Single Cell Transcriptome Sequencing Platform Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Single Cell Transcriptome Sequencing Platform Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Single Cell Transcriptome Sequencing Platform Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Single Cell Transcriptome Sequencing Platform Market Size and Prospective (2020-2031)
2.4.2 Europe Single Cell Transcriptome Sequencing Platform Market Size and Prospective (2020-2031)
2.4.3 China Single Cell Transcriptome Sequencing Platform Market Size and Prospective (2020-2031)
2.4.4 Japan Single Cell Transcriptome Sequencing Platform Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Single Cell Transcriptome Sequencing Platform Historic Market Review by Type (2020-2025)
3.1.1 Global Single Cell Transcriptome Sequencing Platform Sales by Type (2020-2025)
3.1.2 Global Single Cell Transcriptome Sequencing Platform Revenue by Type (2020-2025)
3.1.3 Global Single Cell Transcriptome Sequencing Platform Price by Type (2020-2025)
3.2 Global Single Cell Transcriptome Sequencing Platform Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Single Cell Transcriptome Sequencing Platform Sales Forecast by Type (2026-2031)
3.2.2 Global Single Cell Transcriptome Sequencing Platform Revenue Forecast by Type (2026-2031)
3.2.3 Global Single Cell Transcriptome Sequencing Platform Price Forecast by Type (2026-2031)
3.3 Different Types Single Cell Transcriptome Sequencing Platform Representative Players
4 Global Market Size by Application
4.1 Global Single Cell Transcriptome Sequencing Platform Historic Market Review by Application (2020-2025)
4.1.1 Global Single Cell Transcriptome Sequencing Platform Sales by Application (2020-2025)
4.1.2 Global Single Cell Transcriptome Sequencing Platform Revenue by Application (2020-2025)
4.1.3 Global Single Cell Transcriptome Sequencing Platform Price by Application (2020-2025)
4.2 Global Single Cell Transcriptome Sequencing Platform Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Single Cell Transcriptome Sequencing Platform Sales Forecast by Application (2026-2031)
4.2.2 Global Single Cell Transcriptome Sequencing Platform Revenue Forecast by Application (2026-2031)
4.2.3 Global Single Cell Transcriptome Sequencing Platform Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Single Cell Transcriptome Sequencing Platform Application
5 Competition Landscape by Players
5.1 Global Single Cell Transcriptome Sequencing Platform Sales by Players (2020-2025)
5.2 Global Top Single Cell Transcriptome Sequencing Platform Players by Revenue (2020-2025)
5.3 Global Single Cell Transcriptome Sequencing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Transcriptome Sequencing Platform as of 2024)
5.4 Global Single Cell Transcriptome Sequencing Platform Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Single Cell Transcriptome Sequencing Platform, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Single Cell Transcriptome Sequencing Platform, Product Type & Application
5.7 Global Key Manufacturers of Single Cell Transcriptome Sequencing Platform, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Single Cell Transcriptome Sequencing Platform Sales by Company
6.1.1.1 North America Single Cell Transcriptome Sequencing Platform Sales by Company (2020-2025)
6.1.1.2 North America Single Cell Transcriptome Sequencing Platform Revenue by Company (2020-2025)
6.1.2 North America Single Cell Transcriptome Sequencing Platform Sales Breakdown by Type (2020-2025)
6.1.3 North America Single Cell Transcriptome Sequencing Platform Sales Breakdown by Application (2020-2025)
6.1.4 North America Single Cell Transcriptome Sequencing Platform Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Single Cell Transcriptome Sequencing Platform Sales by Company
6.2.1.1 Europe Single Cell Transcriptome Sequencing Platform Sales by Company (2020-2025)
6.2.1.2 Europe Single Cell Transcriptome Sequencing Platform Revenue by Company (2020-2025)
6.2.2 Europe Single Cell Transcriptome Sequencing Platform Sales Breakdown by Type (2020-2025)
6.2.3 Europe Single Cell Transcriptome Sequencing Platform Sales Breakdown by Application (2020-2025)
6.2.4 Europe Single Cell Transcriptome Sequencing Platform Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Single Cell Transcriptome Sequencing Platform Sales by Company
6.3.1.1 China Single Cell Transcriptome Sequencing Platform Sales by Company (2020-2025)
6.3.1.2 China Single Cell Transcriptome Sequencing Platform Revenue by Company (2020-2025)
6.3.2 China Single Cell Transcriptome Sequencing Platform Sales Breakdown by Type (2020-2025)
6.3.3 China Single Cell Transcriptome Sequencing Platform Sales Breakdown by Application (2020-2025)
6.3.4 China Single Cell Transcriptome Sequencing Platform Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Single Cell Transcriptome Sequencing Platform Sales by Company
6.4.1.1 Japan Single Cell Transcriptome Sequencing Platform Sales by Company (2020-2025)
6.4.1.2 Japan Single Cell Transcriptome Sequencing Platform Revenue by Company (2020-2025)
6.4.2 Japan Single Cell Transcriptome Sequencing Platform Sales Breakdown by Type (2020-2025)
6.4.3 Japan Single Cell Transcriptome Sequencing Platform Sales Breakdown by Application (2020-2025)
6.4.4 Japan Single Cell Transcriptome Sequencing Platform Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 10x Genomics
7.1.1 10x Genomics Company Information
7.1.2 10x Genomics Business Overview
7.1.3 10x Genomics Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.1.4 10x Genomics Single Cell Transcriptome Sequencing Platform Products Offered
7.1.5 10x Genomics Recent Development
7.2 BD
7.2.1 BD Company Information
7.2.2 BD Business Overview
7.2.3 BD Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.2.4 BD Single Cell Transcriptome Sequencing Platform Products Offered
7.2.5 BD Recent Development
7.3 BGI
7.3.1 BGI Company Information
7.3.2 BGI Business Overview
7.3.3 BGI Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.3.4 BGI Single Cell Transcriptome Sequencing Platform Products Offered
7.3.5 BGI Recent Development
7.4 Singleron Bio
7.4.1 Singleron Bio Company Information
7.4.2 Singleron Bio Business Overview
7.4.3 Singleron Bio Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Singleron Bio Single Cell Transcriptome Sequencing Platform Products Offered
7.4.5 Singleron Bio Recent Development
7.5 Seekgene
7.5.1 Seekgene Company Information
7.5.2 Seekgene Business Overview
7.5.3 Seekgene Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Seekgene Single Cell Transcriptome Sequencing Platform Products Offered
7.5.5 Seekgene Recent Development
7.6 ThunderBio
7.6.1 ThunderBio Company Information
7.6.2 ThunderBio Business Overview
7.6.3 ThunderBio Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.6.4 ThunderBio Single Cell Transcriptome Sequencing Platform Products Offered
7.6.5 ThunderBio Recent Development
7.7 Tenk Genomics
7.7.1 Tenk Genomics Company Information
7.7.2 Tenk Genomics Business Overview
7.7.3 Tenk Genomics Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Tenk Genomics Single Cell Transcriptome Sequencing Platform Products Offered
7.7.5 Tenk Genomics Recent Development
7.8 MobiDrop
7.8.1 MobiDrop Company Information
7.8.2 MobiDrop Business Overview
7.8.3 MobiDrop Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.8.4 MobiDrop Single Cell Transcriptome Sequencing Platform Products Offered
7.8.5 MobiDrop Recent Development
7.9 BioMarker
7.9.1 BioMarker Company Information
7.9.2 BioMarker Business Overview
7.9.3 BioMarker Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.9.4 BioMarker Single Cell Transcriptome Sequencing Platform Products Offered
7.9.5 BioMarker Recent Development
7.10 Dynamic Biosystems
7.10.1 Dynamic Biosystems Company Information
7.10.2 Dynamic Biosystems Business Overview
7.10.3 Dynamic Biosystems Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Dynamic Biosystems Single Cell Transcriptome Sequencing Platform Products Offered
7.10.5 Dynamic Biosystems Recent Development
7.11 M20 Genomics
7.11.1 M20 Genomics Company Information
7.11.2 M20 Genomics Business Overview
7.11.3 M20 Genomics Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.11.4 M20 Genomics Single Cell Transcriptome Sequencing Platform Products Offered
7.11.5 M20 Genomics Recent Development
7.12 Illumina
7.12.1 Illumina Company Information
7.12.2 Illumina Business Overview
7.12.3 Illumina Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Illumina Single Cell Transcriptome Sequencing Platform Products Offered
7.12.5 Illumina Recent Development
7.13 QIAGEN
7.13.1 QIAGEN Company Information
7.13.2 QIAGEN Business Overview
7.13.3 QIAGEN Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.13.4 QIAGEN Single Cell Transcriptome Sequencing Platform Products Offered
7.13.5 QIAGEN Recent Development
7.14 Jingxin Biotechnology
7.14.1 Jingxin Biotechnology Company Information
7.14.2 Jingxin Biotechnology Business Overview
7.14.3 Jingxin Biotechnology Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Jingxin Biotechnology Single Cell Transcriptome Sequencing Platform Products Offered
7.14.5 Jingxin Biotechnology Recent Development
7.15 TaKaRa
7.15.1 TaKaRa Company Information
7.15.2 TaKaRa Business Overview
7.15.3 TaKaRa Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.15.4 TaKaRa Single Cell Transcriptome Sequencing Platform Products Offered
7.15.5 TaKaRa Recent Development
7.16 Bio-Rad
7.16.1 Bio-Rad Company Information
7.16.2 Bio-Rad Business Overview
7.16.3 Bio-Rad Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Bio-Rad Single Cell Transcriptome Sequencing Platform Products Offered
7.16.5 Bio-Rad Recent Development
7.17 Mission bio
7.17.1 Mission bio Company Information
7.17.2 Mission bio Business Overview
7.17.3 Mission bio Single Cell Transcriptome Sequencing Platform Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Mission bio Single Cell Transcriptome Sequencing Platform Products Offered
7.17.5 Mission bio Recent Development
8 Single Cell Transcriptome Sequencing Platform Manufacturing Cost Analysis
8.1 Single Cell Transcriptome Sequencing Platform Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Single Cell Transcriptome Sequencing Platform
8.4 Single Cell Transcriptome Sequencing Platform Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Single Cell Transcriptome Sequencing Platform Distributors List
9.3 Single Cell Transcriptome Sequencing Platform Customers
10 Single Cell Transcriptome Sequencing Platform Market Dynamics
10.1 Single Cell Transcriptome Sequencing Platform Industry Trends
10.2 Single Cell Transcriptome Sequencing Platform Market Drivers
10.3 Single Cell Transcriptome Sequencing Platform Market Challenges
10.4 Single Cell Transcriptome Sequencing Platform Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Single Cell Transcriptome Sequencing Platform market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 180
USD 4900.00
(Single User License)
The global Single Cell Transcriptome Sequencing Platform market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 109
USD 4250.00
(Single User License)
The global market for Single Cell Transcriptome Sequencing Platform was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 137
USD 3950.00
(Single User License)
The global Single Cell Transcriptome Sequencing Platform market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 129
USD 2900.00
(Single User License)
The global Single Cell Transcriptome Sequencing Platform market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 174
USD 4900.00
(Single User License)
The global market for Single Cell Transcriptome Sequencing Platform was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 137
USD 3950.00
(Single User License)
The global market for Single Cell Transcriptome Sequencing Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 107
USD 2900.00
(Single User License)
Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
Published Date: 2024-05-27
Pages: 150
USD 3950.00
(Single User License)
Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
Published Date: 2024-05-27
Pages: 156
USD 4350.00
(Single User License)
Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
Published Date: 2024-05-27
Pages: 172
USD 4900.00
(Single User License)
The global Single Cell Transcriptome Sequencing Platform market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 180
The global Single Cell Transcriptome Sequencing Platform market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 109
The global market for Single Cell Transcriptome Sequencing Platform was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 137
The global Single Cell Transcriptome Sequencing Platform market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 129
The global Single Cell Transcriptome Sequencing Platform market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 174
The global market for Single Cell Transcriptome Sequencing Platform was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 137
The global market for Single Cell Transcriptome Sequencing Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 107
Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
Published: 2024-05-27
Pages: 150
Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
Published: 2024-05-27
Pages: 156
Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
Published: 2024-05-27
Pages: 172
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now